keyword
https://read.qxmd.com/read/38657115/morbidity-and-mortality-risks-associated-with-valproate-withdrawal-in-young-men-and-women-with-epilepsy
#1
JOURNAL ARTICLE
Gashirai K Mbizvo, Tommaso Bucci, Gregory Y H Lip, Anthony G Marson
Valproate is the most effective treatment for idiopathic generalised epilepsy. Current guidance precludes its use in women of childbearing potential, unless other treatments are ineffective or not tolerated, because of high teratogenicity. This risk was recently extended to men. New guidance will limit use both in men and women aged <55 years, resulting in withdrawal of valproate from men already taking it, as occurs for women. Whether there are risks of personal harm (including injury or death) associated with valproate withdrawal has not yet been quantified for men or women on valproate, meaning clinicians cannot reliably counsel either sex when discussing valproate withdrawal with them, despite that this concern may be at the forefront of patients' and clinicians' minds...
April 24, 2024: Brain
https://read.qxmd.com/read/38656298/clinical-presentations-of-bupropion-prescription-drug-misuse-a-systematic-review
#2
JOURNAL ARTICLE
Greg Noe, Kaushal Shah, Samantha Ongchuan, Sahil Munjal
BACKGROUND: Among prescribers, bupropion is considered a substance of low misuse potential, with some studies showing lesser misuse potential than caffeine. However, several case reports exist of recreational bupropion misuse and diversion. Our goal is to understand at-risk populations, clinical courses, interventions, and outcomes after acute ingestion of bupropion via oral, intravenous route, and insufflation. METHODS: The systematic review was registered with PROSPERO on August 5, 2023...
April 24, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38653623/discordance-between-pain-specialists-and-patients-on-the-perception-of-dependence-on-pain-medication-a-multi-centre-cross-sectional-study
#3
JOURNAL ARTICLE
Anne Roussin, Zénab Cissé, Vanessa Rousseau, Guillaume Roche, Cécile Lestrade, Alexandre Cauchie, Noémie Delage, Anne Donnet, Elise Van Obberghen, Chantal Wood, Maryse Lapeyre-Mestre, Nathalie Cantagrel
AIM: Patients with chronic non-cancer pain are referred to pain centres to improve their pain treatment. The discontinuation of pain medications in case of poor efficacy can be difficult to accept for patients, particularly opioid analgesics. Previous research has described that from the patients' perspective, the psychological relief of a negative effect of chronic pain and withdrawal symptoms of prescription opioids represent drivers of persistent use and first stage of opioid use disorder, despite insufficient pain relief...
April 12, 2024: Thérapie
https://read.qxmd.com/read/38652996/oligoepilepsy-and-lifelong-seizure-susceptibility-in-epilepsy-with-generalized-tonic-clonic-seizures-alone-experience-at-an-adult-tertiary-center
#4
JOURNAL ARTICLE
Javier Peña-Ceballos, Patrick B Moloney, Ronan D Kilbride, Hany El Naggar, Peter Widdess-Walsh, Norman Delanty
OBJECTIVE: Epilepsy with generalized tonic-clonic seizures alone (GTCA) is the least studied syndrome within the idiopathic generalized epilepsy (IGE) spectrum. We characterize a large cohort of adult patients with GTCA to understand natural history and drug responsiveness. METHODS: In this retrospective single-center study using our epilepsy electronic record, we evaluated clinical characteristics, seizure outcomes, anti-seizure medication (ASM) response including seizure recurrence after ASM withdrawal, and sex differences in a cohort of GTCA patients aged ≥17 years...
April 19, 2024: Epilepsy Research
https://read.qxmd.com/read/38651283/postmarket-safety-communications-on-drugs-approved-in-japan-a-25-year-analysis
#5
JOURNAL ARTICLE
Yusuke Tanaka, Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima, Makoto Miyazawa, Mutsuhiro Ikuma, Yoshihiko Tomita
Drug safety communications (DSCs) are essential tools for communicating important postmarket serious drug safety information to healthcare professionals and patients. Previous studies characterized DSCs issued by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA); however, knowledge about the activities of the Pharmaceuticals and Medical Devices Agency (PMDA)/the Ministry of Health, Labor and Welfare (MHLW) is limited. This study characterized DSCs by the PMDA/MHLW in comparison with previously reported DSCs by the FDA and the EMA...
April 2024: Clinical and Translational Science
https://read.qxmd.com/read/38648814/tranexamic-acid-versus-placebo-in-individuals-with-intracerebral-haemorrhage-treated-within-2-h-of-symptom-onset-stop-msu-an-international-double-blind-randomised-phase-2-trial
#6
JOURNAL ARTICLE
Nawaf Yassi, Henry Zhao, Leonid Churilov, Teddy Y Wu, Henry Ma, Huy-Thang Nguyen, Andrew Cheung, Atte Meretoja, Duy Ton Mai, Timothy Kleinig, Jiann-Shing Jeng, Philip M C Choi, Phuc Dang Duc, Helen Brown, Annemarei Ranta, Neil Spratt, Geoffrey C Cloud, Hao-Kuang Wang, Rohan Grimley, Karim Mahawish, Der-Yang Cho, Darshan Shah, Thai My Phuong Nguyen, Gagan Sharma, Vignan Yogendrakumar, Bernard Yan, Emma L Harrison, Michael Devlin, Dennis Cordato, Nicolas Martinez-Majander, Daniel Strbian, Vincent Thijs, Lauren M Sanders, David Anderson, Mark W Parsons, Bruce C V Campbell, Geoffrey A Donnan, Stephen M Davis
BACKGROUND: Tranexamic acid, an antifibrinolytic agent, might attenuate haematoma growth after an intracerebral haemorrhage. We aimed to determine whether treatment with intravenous tranexamic acid within 2 h of an intracerebral haemorrhage would reduce haematoma growth compared with placebo. METHODS: STOP-MSU was an investigator-led, double-blind, randomised, phase 2 trial conducted at 24 hospitals and one mobile stroke unit in Australia, Finland, New Zealand, Taiwan, and Viet Nam...
April 19, 2024: Lancet Neurology
https://read.qxmd.com/read/38648279/optimal-inhalation-profile-of-pressurized-metered-dry-powder-inhaler-using-a-valved-holding-chamber-a-dynamic-analysis
#7
JOURNAL ARTICLE
Tetsuri Kondo, Toshimori Tanigaki, Makoto Hibino, Shigeto Horiuchi, Kazunari Maeda, Shunichi Tobe, Riko Kamada, Shigehiro Watanabe
Background : The combined use of a pressurized metered-dose inhaler and valved holding chamber (pMDI+VHC) is recommended to improve efficiency and safety; however, aerosol release is likely to vary with the inhalation maneuver. This in vitro study investigated the aerodynamic characteristics and aerosol release features of pMDI+VHC (Aerochamber, Trudell Medical International). Methods : The static and dynamic changes in the airway resistance ( R aw ) during inhalation (withdrawal) through pMDI+VHC were measured...
April 22, 2024: Journal of Aerosol Medicine and Pulmonary Drug Delivery
https://read.qxmd.com/read/38645966/reasons-for-not-entering-opioid-agonist-treatment-a-survey-among-high-risk-opioid-users-in-finland
#8
JOURNAL ARTICLE
Tuire Prami, Mari Pölkki, Jarno Ruotsalainen, Elin Banke Nordbeck, Susanna Meyner, Ari Kaski
Aims: To characterise and understand the untreated high-risk opioid user population in Finland, and to determine the reasons why these people do not enter treatment. Methods: The study setting was a half-year cross-sectional survey in Finland during 2021-2022. An electronic questionnaire with 24 structured questions was concluded in 16 needle exchange units. Participants were opioid-dependent people without opioid agonist treatment (OAT), and they answered the survey voluntarily and anonymously. Results: Of the 167 respondents, 62% were men, 53% were aged ≤34 years, 66% had used opioids for >6 years, and 78% used drugs intravenously (IV) daily...
April 2024: Nordisk Alkohol- & Narkotikatidskrift: NAT
https://read.qxmd.com/read/38645066/nor-laam-loaded-plga-microparticles-for-treating-opioid-use-disorder
#9
Diane Ingabire, Chaolong Qin, Tuo Meng, Aji Alex Moothendathu Raynold, Hadi Sudarjat, E Andrew Townsend, Rudra Pangeni, Sagun Poudel, Michelle Arriaga, Long Zhao, Woon N Chow, Matthew Banks, Qingguo Xu
The treatment landscape for opioid use disorder (OUD) faces challenges stemming from the limited efficacy of existing medications, poor adherence to prescribed regimens, and a heightened risk of fatal overdose post-treatment cessation. Therefore, there is a pressing need for innovative therapeutic strategies that enhance the effectiveness of interventions and the overall well-being of individuals with OUD. This study explored the therapeutic potential of nor-Levo-α-acetylmethadol (nor-LAAM) to treat OUD...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38643163/on-the-way-to-the-azygos-vein-a-road-of-return-rather-than-ruined
#10
REVIEW
Yiping Feng, Yeqing Liu, Shanxiang Xu, Huiming Zhong, Shouyin Jiang
BACKGROUND: The malposition of central venous catheters (CVCs) may lead to vascular damage, perforation, and even mediastinal injury. The malposition of CVC from the right subclavian vein into the azygos vein is extremely rare. Here, we report a patient with CVC malposition into the azygos vein via the right subclavian vein. We conduct a comprehensive review of the anatomical structure of the azygos vein and the manifestations associated with azygos vein malposition. Additionally, we explore the resolution of repositioning the catheter into the superior vena cava by carefully withdrawing a specific length of the catheter...
April 20, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38643152/-everything-is-kind-of-the-same-except-my-mind-is-with-me-exploring-cannabis-substitution-in-a-sample-of-adults-in-early-recovery-from-an-opioid-or-stimulant-addiction
#11
JOURNAL ARTICLE
Corinne A Beaugard, Alexander Y Walley, Maryann Amodeo
BACKGROUND: Recovery from addiction is frequently equated with abstinence. However, some individuals who resolve an addiction continue to use substances, including via substitution (i.e., increased use of one substance after eliminating/ reducing another). Substitution may play a distinct role during early recovery (≤ 1 year), as this period is marked by dramatic change and adjustment. Cannabis is one of the most used substances and is legal for medical and recreational use in an increasing number of states...
April 20, 2024: Harm Reduction Journal
https://read.qxmd.com/read/38642310/inpatient-opioid-withdrawal-a-qualitative-study-of-the-patient-perspective
#12
JOURNAL ARTICLE
Danielle M Babbel, Patricia Liu, David R Chen, Valerie M Vaughn, Susan Zickmund, Kennedi Bloomquist, Tobias Zickmund, Elizabeth F Howell, Stacy A Johnson
Opioid withdrawal is common among hospitalized patients. Those with substance use disorders exhibit higher rates of patient-directed discharge. The literature lacks information regarding the patient perspective on opioid withdrawal in the hospital setting. In this study, we aimed to capture the patient-reported experience of opioid withdrawal during hospitalization and its impact on the desire to continue treatment for opioid use disorder after discharge. We performed a single-center qualitative study involving semi-structured interviews of hospitalized patients with opioid use disorder (OUD) experiencing opioid withdrawal...
April 20, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38639503/retraction-note-study-on-the-functions-and-mechanism-of-immune-functions-of-human-telomerase-reverse-transcriptase-regulating-dendritic-cells-treating-sepsis
#13
JOURNAL ARTICLE
H-M Chen, L-Q Wang, H-P Wan, H-Z Wei, L-C Ke, C-Y Liu, Q-Y Tan
The article "Study on the functions and mechanism of immune functions of human telomerase reverse transcriptase regulating dendritic cells treating sepsis", by H.-M. Chen, L.-Q. Wang, H.-P. Wan, H.-Z. Wei, L.-C. Ke, C.-Y. Liu, Q.-Y. Tan, published in Eur Rev Med Pharmacol Sci 2016; 20 (21): 4500-4507-PMID: 27874963 has been retracted by the Editor in Chief for the following reasons. Some concerns were raised on PubPeer (https://pubpeer.com/publications/3604386A706802443E51758A893D6F) about Figures 3, 4, and 5 showing some overlaps and similar bands in Western blots figures...
April 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38639499/retraction-note-microrna-199a-regulates-myocardial-fibrosis-in-rats-by-targeting-sfrp5
#14
JOURNAL ARTICLE
M-H Chen, J-C Liu, Y Liu, Y-C Hu, X-F Cai, D-C Yin
The article "MicroRNA-199a regulates myocardial fibrosis in rats by targeting SFRP5", by M.-H. Chen, J.-C. Liu, Y. Liu, Y.-C. Hu, X.-F. Cai, D.-C. Yin, published in Eur Rev Med Pharmacol Sci 2019; 23 (9): 3976-3983-DOI: 10.26355/eurrev_201905_17827-PMID: 31115026 has been retracted by the authors. This paper has been questioned on PubPeer (https://pubpeer.com/publications/6417BECD38A43595A89D977A1CBDF8). In particular, concerns were raised about Figures 2C and 4C, potentially showing three panels with overlapping details of a single image...
April 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38639498/retraction-note-long-non-coding-rna-dleu7-as1-promotes-the-occurrence-and-development-of-colorectal-cancer-via-wnt-%C3%AE-catenin-pathway
#15
JOURNAL ARTICLE
X-B Liu, C Han, C-Z Sun
The article "Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway", by X.-B. Liu, C. Han, C.-Z. Sun, published in Eur Rev Med Pharmacol Sci 2018; 22 (1): 110-117-DOI: 10.26355/eurrev_201801_14107-PMID: 29364477 has been retracted by the authors as the data cannot be reproduced by further research. This paper has been questioned on PubPeer (https://pubpeer.com/publications/AC72791669051B50085FEC00D0EF8F). In particular, concerns were raised about Table I and the originality of Figures 3A and 3C...
April 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38639166/how-seeking-transfer-often-fails-to-help-define-medically-inappropriate-treatment
#16
JOURNAL ARTICLE
Douglas B White, Thaddeus M Pope
On September 1, 2023, Texas made important revisions to it its decades-old statute granting legal safe harbor immunity to physicians who withhold or withdraw life-sustaining treatment over the objection of critically ill patients' surrogate decision-makers. However, lawmakers left untouched glaring flaws in a key safeguard for patients-the transfer option. The transfer option is ethically important because, when no hospital is willing to accept the patient in transfer, that fact is taken as strong evidence that the surrogates' treatment requests fall outside accepted medical practice...
March 2024: Hastings Center Report
https://read.qxmd.com/read/38635977/opioid-overdoses-and-take-home-naloxone-interventions-ethnographic-evidence-for-individual-level-barriers-to-treatment-of-opioid-use-disorders-in-rural-appalachia
#17
JOURNAL ARTICLE
Victor Garcia, Lisa McCann, Erick Lauber, Christian Vaccaro, Melissa Swauger, Daniel Alex Heckert
Introduction : Research indicates that take-home naloxone (THN) is saving lives across rural Appalachia, but whether it also results in treatment for opioid use disorders (OUDs) remains unclear. This study involves a detailed qualitative analysis of interviews with 16 individuals who had overdosed on opioids 61 times to understand why a THN intervention does not routinely lead to OUD treatment. Methods : This study builds upon a one-year (2018) qualitative study on community responses to opioid overdose fatalities in four adjacent rural counties in Western Pennsylvania...
April 18, 2024: Substance Use & Misuse
https://read.qxmd.com/read/38634548/identifying-vulnerabilities-to-nsaid-adverse-events-in-the-u-s-population-an-analysis-of-preexisting-conditions-and-sex
#18
JOURNAL ARTICLE
Paul Rogers, Dong Wang, Zhiyuan Lu, Beverly Lyn-Cook
Purpose: In 2005, the Food and Drug Administration (FDA) issued a decision memorandum regarding nonsteroidal anti-inflammatory drugs (NSAIDs). The memorandum recommended the withdrawal of certain NSAIDs due to potential cardiovascular adverse effects. It highlighted the issue of cardiovascular risk associated with NSAIDs as a class. The NSAID medication guide includes a wide range of adverse drug reactions (ADRs), such as increased blood pressure, liver failure, allergic reactions, heart attack, and intestinal bleeding...
April 18, 2024: Journal of Women's Health
https://read.qxmd.com/read/38634140/activation-of-asic3-erk-pathway-by-paeoniflorin-improves-intestinal-fluid-metabolism-and-visceral-sensitivity-in-slow-transit-constipated-rats
#19
JOURNAL ARTICLE
Yuan Deng, Qiong Zhao, Hong-Yun Zhou, Zi-Qi Zhang, Yu Zhan
Slow transit constipation (STC) is one of the most common gastrointestinal disorders in children and adults worldwide. Paeoniflorin (PF), a monoterpene glycoside compound extracted from the dried root of Paeonia lactiflora, has been found to alleviate STC, but the mechanisms of its effect remain unclear. The present study aimed to investigate the effects and mechanisms of PF on intestinal fluid metabolism and visceral sensitization in rats with compound diphenoxylate-induced STC. Based on the evaluation of the laxative effect, the abdominal withdrawal reflex test, enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, western blot, and immunohistochemistry were used to detect the visceral sensitivity, fluid metabolism-related proteins, and acid-sensitive ion channel 3/extracellular signal-regulated kinase (ASIC3/ERK) pathway-related molecules...
April 17, 2024: Kaohsiung Journal of Medical Sciences
https://read.qxmd.com/read/38631312/study-on-risk-factors-and-receiver-operator-characteristic-curve-of-iatrogenic-withdrawal-syndrome-in-pediatric-intensive-care-units-a-retrospective-study
#20
JOURNAL ARTICLE
Yi Wang, Ying Zheng, Lijia Chen, Lingjie Lin, Binwu Chen, Zhengfeng Lin, Shihui Bao
OBJECTIVE: To investigate the independent risk factors associated with iatrogenic withdrawal syndrome in pediatric intensive care units (PICUs) and to establish receiver operator characteristic (ROC) curve to facilitate the diagnosis of iatrogenic withdrawal syndrome in clinical settings. METHOD: Pediatric patients who received analgesic and sedative medication at a tertiary hospital in the southern Zhejiang region of China between January 2016 and December 2022 were selected for the study...
April 17, 2024: Pharmacology
keyword
keyword
45956
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.